GSK3901961
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3901961, covering 2024-05-10 to 2024-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer [Phase 1]